FDA Inspection 898985 — Lucasti Christopher, D.O.
The FDA completed an inspection of Lucasti Christopher, D.O. on Oct 16, 2014 in Somers Point, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 16, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somers Point, NJ (United States)
Additional details
Clinical Investigator (CI)